P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FROM THE DEFIFRANCE STUDY

Documenti analoghi

• P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FROM THE DEFIFRANCE STUDY
  di: M. Mohty, et al.
  Pubblicazione: (2022-06-01)
• Defibrotide for the Treatment of Veno‐Occlusive Disease/Sinusoidal Obstruction Syndrome in Paediatric Patients Who Did Not Receive Haematopoietic Stem Cell Transplantation: Case Reports of Patients From a German Academic Hospital
  di: Katharina Kleinschmidt, et al.
  Pubblicazione: (2025-02-01)
• Defibrotide in the treatment of hepatic veno-occlusive disease
  di: Fulgenzi A, et al.
  Pubblicazione: (2016-10-01)
• A case report of severe veno-occlusive disease following autologous stem cell transplantation successfully treated with Defibrotide
  di: Gholamreza Bahoush, et al.
  Pubblicazione: (2020-09-01)
• A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting
  di: William Tappe MD, et al.
  Pubblicazione: (2020-09-01)